SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -72.7% | 30,866 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $11 | +37.5% | 30,866 | +44.0% | 0.00% | 0.0% |
| Q1 2023 | $8 | -100.0% | 21,433 | 0.0% | 0.00% | -60.0% |
| Q4 2022 | $18,990 | -69.9% | 21,433 | -46.8% | 0.01% | -70.6% |
| Q3 2022 | $63,000 | -22.2% | 40,300 | 0.0% | 0.02% | -19.0% |
| Q2 2022 | $81,000 | -13.8% | 40,300 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $94,000 | -49.7% | 40,300 | 0.0% | 0.02% | -47.5% |
| Q4 2021 | $187,000 | -50.7% | 40,300 | -19.0% | 0.04% | -54.0% |
| Q3 2021 | $379,000 | -21.4% | 49,733 | 0.0% | 0.09% | -20.9% |
| Q2 2021 | $482,000 | +17.3% | 49,733 | 0.0% | 0.11% | +7.8% |
| Q1 2021 | $411,000 | +21.2% | 49,733 | 0.0% | 0.10% | +20.0% |
| Q4 2020 | $339,000 | +153.0% | 49,733 | +314.4% | 0.08% | +193.1% |
| Q3 2020 | $134,000 | +78.7% | 12,000 | 0.0% | 0.03% | +70.6% |
| Q2 2020 | $75,000 | +240.9% | 12,000 | 0.0% | 0.02% | +183.3% |
| Q1 2020 | $22,000 | -46.3% | 12,000 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $41,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |